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Previous in vivo and in vitro studies from our laboratory have revealed a line ofpharmacolog-
ical evidence supporting histamine H3 receptor(s) involvement in the control of gastric acid
secretion. We have recently extended our studies to the human gastric tumoral cell HGT-1.
This cellwas found to contain an H3 receptor inhibiting basal and carbachol-stimulated inositol
phosphate formation. Furthermore, we were able to solubilize and affinity-purify this receptor
in the formofa single 70kDaprotein. These findings are the firstbiochemical description ofthe
H3 receptor subtype and the first direct demonstration that this subtype can occur on a
non-neural cell. Furthermore, they provide a molecular basis to explain its suggested inhibitory
role in gastric physiology.
INTRODUCTION
The novel "H3" histamine receptor subtype was originally characterized on brain
histaminergic nerves as an autoreceptor downregulating histamine synthesis and
release [1]. The localization of this receptor was, however, rapidly extended to
serotoninergic, cholinergic, and non-cholinergic fibers, in brain as well as in periph-
eral tissues such as airways, lung, and intestine [2,3].
We summarize here recent studies from our laboratory, supporting the hypothesis
that H3 receptors areverylikely tobe involved in the controlofgastric acid secretion.
Furthermore, we report preliminary results onbiochemical andfunctional character-
ization ofagastric H3 receptor in the human gastric cell line HGT-1.
PHARMACOLOGICAL EVIDENCE
The first evidence for a gastric H3 receptor subtype came from in vivo studies
carried out in our laboratory on fistula cats by Hervatin et al. [4] and Bado et al. [5].
These studies showed that stimulation ofacid secretion by meal or pentagastrin was
potently and dose-dependently inhibited by the specific H3 agonist Rao-methylhista-
mine (Ra-MeHA). Furthermore, this inhibition was itselfinhibitedbythespecificH3
antagonist thioperamide (Figs. 1, 2). The fact that Ra-MeHA inhibited pentagastrin
stimulation suggests that the putative H3 receptor(s) should be located downstream
of the gastrin receptor. Furthermore, an extrinsic cholinergic vagal mediation is
apparently excluded, since similar findings were observed for the main stomach and
the denervated Heidenhain pouch.
The possibility that Ra-MeHA inhibition of (penta)gastrin stimulation could be
mediated by histamine cell H3 receptors was investigated by Sandvik et al. on the
isolated rat stomach [6]. These authors found that Ra-MeHA inhibited basal and
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FIG. 1. Dose-dependent
inhibition for the H3-recep-
tor agonist (R)a-methylhis-
tamine (Ra-MeHA) on
pentagastrin-stimulated gas-
tric acid secretion from the
main stomach in cats with
gastric fistula. Redrawn
120 min from [5].
gastrin-stimulated vascular histamine release in a ranitidine-insensitive manner (Fig.
2). This finding is consistent with the presence of an H3 autoreceptor on the
histamine-secreting cell, in agreement with the report of H3 autoreceptors on brain
histaminergic nerves [1] and with the early suggestion by H'akanson et al. that
histamine inhibits its own synthesis and release in the gastric mucosa [7]. The
intervention of an H2-type receptor was previously postulated because the stimula-
tion ofgastric mucosal histamine release, evoked bypentagastrin injection in the rat,
was reported to be increased after infusion ofmetiamide, burimamide, or cimetidine
[8,9]. These findings, which contrast with the lackofeffect ofranitidine in thein vitro
CAT, HEIDENHAIN POUCH
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FIG. 2. Effect of H3-receptor ago-
nist(R)a-methylhistamine (Rot-MeHA)
alone or together with the H3-receptor
antagonist, thioperamide (Thioperam-
ide) on bactopeptone (BP) meal-stim-
ulated gastric acid secretion from the
denervated Heidenhain pouch in con-
scious cats. Redrawn from [5].
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FIG. 3. Time course of gastric histamine release by H-13-receptor antagonist thioperamide by isolated
rabbit gastric glands (A) and dose-response curves for histamine, 1-13-receptor agonist (R)a-methylhista-
mine, or H3-receptor antagonist thioperamide on '4C-aminopyrine accumulation in these glands (B).
Reprinted from [10].
studyofSandvik et al. [6], mightbe, however, inherent in the in vivo situation and the
doses used.
Evidence for H3modulation ofother mediators of acid secretion was investigated
on the same experimental model by Moizo et al. [10]. These studies demonstrated
that Ra-MeHA strongly potentiated carbachol-induced vascular gastrin release and
that this effect was totally suppressed by thioperamide. Such a finding might be
interpreted as evidence for an H3 receptor on the gastrin cell. Since in this study,
Rea-MelA concomitantly reversed carbachol inhibition of somatostatin release,
however, gastrin release potentiation could be secondary to this effect. Thus, in
addition to its putative location on the histamine-secreting cell, the H3 receptor
could also occur on other gastric endocrine cells, such as gastrin and somatostatin
cells.
In an attempt to gain a deeper insight into the role ofH3receptors in the cellular
mechanisms regulating acid secretion, we carried out further studies on isolated
rabbit gastric glands [11]. We found that Ret-MeHA inhibited and thioperamide
enhanced basal histamine release (Fig. 3), in agreementwith the suggested existence
of an inhibitory H3 receptor on gastric histamine cells. In addition, thioperamide-
enhanced histamine release was accompanied by the stimulation of14C-aminopyrine
accumulation by the glands. Thioperamide stimulation of 14C-aminopyrine accumu-
lation was still present, however, after blockade of the parietal cell H2 receptor by
ranitidine (Fig.3). Moreover, Ra-MeHAalsoinhibitedcarbachol- and evenhistamine-
stimulated 14C-aminopyrine accumulation (Fig. 4). These findings do not conflict
with the presence of an H3 receptor on histaminocytes but argue strongly for the
additional presence of an H3 receptor on the parietal cell itself(Fig. 4).
BIOCHEMICAL EVIDENCE
A direct demonstration of gastric H3 receptor(s) was recently attempted in our
laboratory, using the human gastric tumoral cell HGT-1. The great suitability ofthis
model for the study ofgastric acid secretion receptors, particularly histamine H2 and
somatostatin receptors had been previously shown [12,13,14]. Using3HNoa-MeHA as
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MODEL FOR HISTAMINE REGULATION OF ACID SECRETION
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FIG. 4. Model for gas-
Histamine cell Parietal cell tric histamine receptors.
a receptor ligand, Cherifi et al. [15] characterized high-affinity specific binding sites
ofan equilibrium constant (KD) of0.85 + 0.06 nM and 2 + 0.5 nM in the absence and
the presence ofGTP(-y)S, respectively. Theywere able to solubilize these sites and to
purify them further (86 percent purity), using a thioperamide affinity column. The
binding of3(H)Not-MeHA to the purified sites showed a KD of 1.6 + 0.1 nM. It was
competitively displaced byNa-MeHA(IC50 = 5.8nM), Ra-MeHA(IC50 = 9 + nM),
and thioperamide (IC50 = 85 + 10 nM) but not by GTP(-y)S, nor the H2 and H1
antagonists famotidine and mepyramine, respectively. On the other hand, Cherifi et
al. demonstrated a thioperamide-sensitive, ranitidine-insensitive inhibition of basal
and carbachol-stimulated inositol phosphate formation by Ra-MeHA in the HGT-1
cell (Fig. 5) [15].
These findings are the first direct evidence for the existence of H3 receptors as a
distinct biochemical entity and for the occurrence of this receptor on a non-neural
cell. They further support the hypothesis that this novel receptor subtype is nega-
tively coupled to phosphatidylinositol turnover, a signaling pathway consistent with
its general inhibitory action, as reported in the above studies.
150-
100 _ FIG. 5. Effect of 10 nM (R)a-
<1 T + methylhistamine (A), 0.5 ,uM thiope-
&o ramide (O), and Ra-MeHA +
_ b st l thioperamide (A) on basal InsP3 for-
CO . I mation in HGT-1 cells. Cells pre-
Ii . V T l <labeled for 48 hours with (3H) C50 myoinositol were incubated at 37°C
I i with Ra-MeHA and/orthioperamide.
At different times, cellular InsP3 was
isolated by a Dowex chromatography
column eluted with 0.1, 0.2, 0.4, and 1
M ammonium formate and then esti-
0 0 mated by counting (3H) InsP3 with a
0 10 20 30 liquid spectrophotometer. Mean val-
Time (sec) ues ± SE ofthree experiments.
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